Studies in the Area of Tumor Necrosis Factors Reported from School of Pharmacy (Siponimod As a Novel Inhibitor of Retinal Angiogenesis: In Vitro and In Vivo Evidence of Therapeutic Efficacy S)

Press/Media

Period	8 Sep 2023

Media coverage

Title	Studies in the Area of Tumor Necrosis Factors Reported from School of Pharmacy (Siponimod As a Novel Inhibitor of Retinal Angiogenesis: In Vitro and In Vivo Evidence of Therapeutic Efficacy S)
Media name/outlet	Chemicals & Chemistry Daily
Country/Territory	United States
Date	8/09/23
URL	metabase.moreover.com/noarticleurl?type=psh&lni=694C-4HK1-JBSP-11S3-00000-00
Persons	Katie Ryan